Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

COVID-19: Online pharmacies see rise in prescription nominations

The COVID-19 pandemic has seen electronic prescription service (EPS) nominations increase “significantly” for distance-selling pharmacies Pharmacy2U and Echo.

Pharmacy2U saw prescription nominations rise by 20,168 in the final week of March compared to the previous week, according to data published by NHS Digital last week (March 30).

This brought the total number of active EPS nominations for Pharmacy2U to 441,265 at the time the data was published, the highest number of any pharmacy in England.

C+D has contacted Pharmacy2U for comment.

Echo, which is owned by LloydsPharmacy, recorded the second highest increase during the  week ending March 27. A 7,568 rise in nominations brought Echo’s total number of active nominations to139,308 – the third highest in England.

There has been an “extraordinary demand”, with patient nominations “up significantly” since the start of the COVID-19 crisis, Echo told C+D yesterday (April 1).

“The self-isolated, shielded and those just practising social distancing have seen this as an opportunity to explore online options and our demographic is shifting,” it added.

To cope with the increased demand, Echo is “currently recruiting” more staff.

“Like in bricks and mortar pharmacies, our pharmacists and teams are working extremely hard,” the company  said.

Has your number of EPS nominations increased recently?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD006422

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel